GHK-Cu for curly hair: separating peptide hype from real evidence

What did @gelila_xo actually say?

Straightforwardly: nothing about peptides. The transcript is a motivational caption, likely text-over-video, that reads "I'm saying what I look like giving up today / When tomorrow / It might be the day I win." The creator's own hashtag tells the real story: #curlyhairproducts. This is a curly hair product showcase video, not a peptide therapy video.

There are no claims about BPC-157, TB-500, GHK-Cu, MK-677, or any other bioactive peptide. There are no dosing recommendations, no healing claims, no recovery protocols. The video was miscategorized into the peptide therapy bucket, almost certainly by an automated tagging system that flagged something unrelated to the actual content.

Before we can fact-check claims, the claims have to exist. They do not here.

Does the science back this up?

There is no scientific claim to evaluate from this transcript. What we can say is that the sentiment expressed, persistence being more valuable than any single moment of failure, does have some grounding in behavioral psychology literature, even if that is not what this creator was discussing.

Research on self-efficacy by Bandura (1997, Psychological Review) consistently shows that maintaining effort despite short-term setbacks correlates with better long-term outcomes across health and performance domains. That is about as far as we can stretch a science analysis of "tomorrow might be the day I win."

The peptide category this video was placed in is genuinely complex territory. Peptides like GHK-Cu have published data on wound healing and skin remodeling (Pickart et al., 2015, Journal of Aging Science). BPC-157 has animal model data on tissue repair (Sikiric et al., 2018, Current Pharmaceutical Design). But none of that is relevant here because the creator said none of it.

What did they get wrong (or right)?

The creator got nothing wrong, because the creator made no health claims. Credit where it is due: a motivational caption about not giving up is not misinformation. It is a caption about hair products.

The categorization system, however, got something meaningfully wrong. Placing a curly hair product video into a peptide therapy fact-check queue wastes review resources and, more importantly, illustrates a real problem with automated content classification in health contexts. When a system flags the wrong content, it creates blind spots for the content that actually needs scrutiny.

Peptide therapy is an area where genuine misinformation is widespread. Creators do make unsupported claims about BPC-157 regenerating organs, about CJC-1295 being equivalent to pharmaceutical HGH, about MK-677 being safe for self-administration. Those videos exist and need fact-checking. This one does not.

What should you actually know?

If you landed here looking for information on peptide therapy, the short version is this: most peptides discussed in wellness content exist in a regulatory gray zone. They are not FDA-approved drugs for most claimed uses. Compounded peptides are not equivalent to any approved pharmaceutical product.

BPC-157, for example, has no completed Phase III clinical trials in humans as of early 2024. TB-500 (thymosin beta-4) is banned in competitive sports by WADA. MK-677 is a research chemical, not an approved drug. Anyone claiming these compounds definitively cure injury, reverse aging, or replace medical care is outpacing the evidence by a significant margin.

If you are considering peptide therapy, that conversation belongs with a licensed clinician who can review your full health history, not a TikTok comment section. FormBlends operates as a regulated telehealth platform specifically because this category requires real medical oversight, not crowdsourced dosing protocols.